Rayzebio Inc Net Income per Employee (RYZB), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Rayzebio Inc   (NASDAQ: RYZB)
 

Rayzebio Inc Net Income per Employee

RYZB's Quarterly Results, Trends, Rankings, Statistics
Rayzebio Inc 's Income per employee fell in the third quarter 2023 on a trailing twelve month basis to $ 7,242,692, but the productivity of Rayzebio Inc 's 52 employees remained above the company average.
The Healthcare sector has seen employees of 143 other companies achieving higher income per employee. While Rayzebio Inc 's total ranking has deteriorated compared to the previous quarter from to 3412.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RYZB Net Income per Employee (Sep 30 2023)
III. Quarter		 (Sep 30 2022)
III. Quarter


Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 7,242,692 7,592,519 - - -
RYZB's Total Ranking # 3412 # # # #
Seq. Net Income Change - - - - -

RYZB Company Profile >> Back to RYZB Efficiency Comparisons >> Compare RYZB Net Income per Employee to its Competitors

RYZB Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 422
Overall Market # 3412

Net Income per Employee Statistics
High Average Low
$ -349,827 $ -349,827 $ -349,827
(Sep 30 2023)  







Companies with similar Income per Employee for 12 month ending Sep 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2023Number of Employees Sep 30 2023
Vertex Pharmaceuticals Inc  8,567,160.49 $ 3,469.700  Million 405 
Scynexis Inc   4,011,000.00 $ 72.198  Million 18 
Royalty Pharma Plc  3,724,720.00 $ 372.472  Million 100 


Date modified: 2026-08-31T17:00:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.